GM Nominates Novartis CEO Jimenez for Board of Directors
General Motors has announced that it is nominating Novartis CEO Joseph Jimenez to its board of directors in light of a concurrent announcement that current board-member E. Neville Isdell will not stand for re-election. Isdell’s retirement is pursuant to the GM Board of Director’s retirement age policy.
Jimenez has been the CEO of Novartis since 2010. He has also served in senior leadership roles in the H.J. Heinz Company, as a nonexecutive director at AstraZeneca PLC, UK, an advisor for Blackstone Group, and at the Clorox Company, with whom he began his career in 1984.
“Joe brings a wealth of consumer insights gained from a distinguished career in the pharmaceutical and packaged goods industries, as well as a proven focus on enhancing shareholder value over time,” said GM Chairman Tim Solso. “We look forward to leveraging his expertise in product innovation and global consumer markets.”
Isdell, 71, has been with the GM Board of Directors since 2009. Isdell is arguably best known as the chairman and CEO of Coca-Cola from 2004 and 2008 and chairman until 2009.
“We have made significant progress and benefited greatly from Neville’s insight and experience, especially in global brand management,” said GM CEO Mary Barra. “I am thankful for the contributions he has made to our board and company.”
The Boyd name has been serving the Hendersonville regions automotive needs for 79 years. Today Les Boyd, son of Cam Boyd, is in charge of the entire operation. Les is an avid family man and actively involved in his community. He has been in the captain’s seat since 2001 and has successfully performed his role as owner and manager with a hands on approach that has earned him both favor and respect from his employees and customers. In his spare time, Les enjoys writing about the cars he loves most.